HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

GV143253A

a trinem

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amides: 2428
  - Lactams: 2198
    - GV143253A: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Lactams: 2198
    - GV143253A: 1

Experts

1.	Braggio, Simone: 1 article (02/2003)
2.	Di Modugno, Enza: 1 article (02/2003)
3.	Ferrari, Livia: 1 article (02/2003)
4.	Iavarone, Laura: 1 article (02/2003)

Related Diseases

1.

02/01/2003 - "The results suggest that if the time of exposure to the pathogen above the MIC is at least 30% of the dosing interval, GV143253A could have a role in the clinical treatment of infections caused by MRSA, which is difficult to eradicate with current antibiotics."
02/01/2003 - "In addition, in order to compare the therapeutic efficacy of GV143253A to that of vancomycin in a thigh infection caused by MRSA in immunocompetent mice, suitable dosing regimens were designed on the basis of previous pharmacokinetic-pharmacodynamic findings for GV143253A and on the human pharmacokinetic profile of the glycopeptide. "

Related Drugs and Biologics

1.	Vancomycin
2.	Glycopeptides
3.	Anti-Bacterial Agents (Antibiotics)